Fabio Shigehara Email

CFO Brazil (Jun 17- Feb 20) / CFO LatAm (Feb 20 - May 21) / North America Finance Director - Current . Guerbet

Current Roles

Employees:
2864
Revenue:
$575.7M
About
Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. \n\nA pioneer since more than 90 years in the field of contrast media, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €817 million in revenue in 2019. \n\nIts total workforce is of over 2,800 employees. Achieve, Cooperate, Care and Innovate are the values that Guerbet's employees share and practice every day. Working at Guerbet means playing a unique part in the future of medical imaging. Passionate about its business, the company strive day in, day out to combine performance, quality and sustainable development. \n\nFor more information about Guerbet, please go to www.guerbet.com and follow Guerbet on Twitter @GuerbetGroup
Guerbet Address
2111 East Galbraith Road
Bloomington, IN
United States

Past Companies

GuerbetCFO Brazil (Jun 17- Feb 20) / CFO LatAm (Feb 20 - May 21) / North America Finance Director - Current
Zoetis Inc.Senior Finance Executive & Business Sr. Controller Brazil (Former Pfizer Animal Health) at Zoetis
Telemar Norte LesteReal Estate Senior Controller

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.